Live Breaking News & Updates on சிவப்பு மரம் துணிகர மூலதனம்
Stay updated with breaking news from சிவப்பு மரம் துணிகர மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Ceribell, Inc., a Mountain View, CA-based developer of a non-invasive brain monitor, completed a $53m Series C financing. The round was co-led by Longitude Capital and The Rise Fund with participation from new investors RA Capital Management, Redmile Group and Red Tree Venture Capital, with existing shareholders. The company will use the funds to further expand its commercial presence in emergency departments and intensive care units globally. The Ceribell® technology platform is designed to address the need for faster diagnosis in patients with suspicion of seizure. Led by Jane Chao, CEO and Co-Founder, Ceribell provides an FDA cleared, point of care brain monitor that uses real-time cloud computing and the proprietary Clarity™ machine learning algorithm to provide rapid answers at the bedside for immediate and precise treatment. The Ceribell EEG System received FDA 510(k) clearance in 2017 and is commercially available in the United States. ....
Ceribell Announces Completion Of $53 Million Series C Financing Proceeds will be used to expand commercialization of the Ceribell Rapid Response EEG and support pipeline product development to drive future clinical applications News provided by Share this article MOUNTAIN VIEW, Calif., April 29, 2021 /PRNewswire/ Ceribell, Inc., innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced today the completion of a $53 million Series C financing, co-led by Longitude Capital and The Rise Fund. Other new investors include RA Capital Management, Redmile Group and Red Tree Venture Capital, with additional support from existing shareholders. The Ceribell® technology platform is designed to address the need for faster diagnosis in patients with suspicion of seizure. The company will use financing proceeds to further expand Ceribell s commercial footprint in emergency departments and intensive care units globally. In addition, Ceri ....
socaltech.com San Diego-based Pipeline Therapeutics, a biopharmaceuticals firm focused on small molecules for neuroregeneration, said on Thursday that it has raised $80M in its Series C funding. The funding included Perceptive Advisors, Franklin Templeton, Casdin Capital, Samsara BioCapital, Suvretta Capital, Red Tree Venture Capital, plus Versant Ventures, Sectoral Asset Management, Cleva Pharma (a Brace Pharma affiliate), Hadean Ventures, RBV Capital and Helicase Venture, as well as several other undisclosed investors. The lead was a healthcare-focused new investor , according to the company. The company said it will use the new funding to advance development candidates for a number of its programs. Pipeline Therapeutics is led by President and CEO Carmine Stengone. ....